
hPL-IN-2
CAS No. 24900-61-6
hPL-IN-2( —— )
Catalog No. M37044 CAS No. 24900-61-6
hPL-IN-2 is a potent, reversible and non-competitive inhibitor of Pancreatic lipase (IC50: 1.63 μM) that can be used to investigate obesity-related diseases.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
2MG | 67 | Get Quote |
![]() ![]() |
5MG | 100 | Get Quote |
![]() ![]() |
10MG | 167 | Get Quote |
![]() ![]() |
25MG | 272 | Get Quote |
![]() ![]() |
50MG | 403 | Get Quote |
![]() ![]() |
100MG | 573 | Get Quote |
![]() ![]() |
500MG | 1197 | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NamehPL-IN-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionhPL-IN-2 is a potent, reversible and non-competitive inhibitor of Pancreatic lipase (IC50: 1.63 μM) that can be used to investigate obesity-related diseases.
-
DescriptionhPL-IN-2 (compound 2u) is a potent, reversible, and non-competitive inhibitor of pancreatic lipase (IC50: 1.63 μM) and can be used in anti-obesity research.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number24900-61-6
-
Formula Weight443.11
-
Molecular FormulaC19H11Cl4NO3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (225.68 mM; Ultrasonic )
-
SMILESO=C(NC1=CC=C(OC2=CC=C(Cl)C=C2)C(Cl)=C1)C=3C=C(Cl)C=C(Cl)C3O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Zhao Y, et al. Design, synthesis and biological evaluation of salicylanilides as novel allosteric inhibitors of human pancreatic lipase. Bioorg Med Chem. 2023 Aug 15;91:117413..?
molnova catalog



related products
-
Sudan I
Sudan I is an organic compound, typically classified as an azo dye.
-
(+)-Bicuculline meth...
(+)-Bicuculline methiodide is a γ-aminobutyric acid type A (GABAA) receptor blocker that crosses the rat blood-brain barrier (BBB) and blocks epileptogens, which can be used to study neurological disorders such as epilepsy. (+)-Bicuculline methiodide reduces liver injury in septic rats.
-
[Des-Arg9]-Bradykini...
[Des-Arg9]-Bradykinin acetate is a Bradykinin(B1) receptor agonist.